Advancing Characterization Testing, Biomarker Discovery & Streamlined Logistics for
Donor-Derived Material to Meet Clinical Demand for Allogeneic Therapies
Welcome to the 3rd Donor Selection & Cell Source Summit
Transfroming Off-the-Shelf Therapies from the Start
The ONLY Meeting Keeping Donors at the Heart of the Conversation
Together, We Can Revolutionize the Future of Allogeneic Therapies & Significantly Enhance Patient Outcomes
How far can the allogeneic cell therapy field progress without high quality starting material and robust donor selection processes?
The allogeneic cell therapy field continues to progress rapidly. With over 600 clinical trials currently underway, the industry must address the critical challenges associated with donor-derived materials to meet growing demand.
The 3rd Donor Selection & Cell Source Summit returns to San Diego as the premier platform for allogeneic biopharma, blood banks, and apheresis suppliers to unite to pull back the curtain on donor screening strategies, spearhead new donor recruitment and retention strategies to move forward together in ensuring a consistent and reliable supply of starting material required for clinical trials.
Bringing together experts in supply chain, analytical development, quality control, cryobiology, and more, this event is your one-stop shop for scientific and logistical insights into sourcing and scaling donor-derived starting material for late-stage clinical trials.
Expert Speaker Faculty Includes:
Our 2025 Partners
I appreciate the intimacy of the conference size, which fosters more dialogue and interaction with fellow participants''
Senior Manager - Process Data Systems & Analytics, AlloVir - 2023 Attendee